论文部分内容阅读
通过观察比较尿激酶(UK)、链激酶(SK)和重组组织型纤溶酶原激活剂(rt-PA)对急性心肌梗死(AMI)患者静脉溶栓的治疗结果,以探讨不同溶栓剂对AMI患者的疗效和安全性。
To observe the therapeutic effect of intravenous thrombolysis in patients with acute myocardial infarction (AMI) by comparing urokinase (UK), streptokinase (SK) and recombinant tissue plasminogen activator (rt-PA) Efficacy and safety of AMI patients.